Evidence map›Paper›PMID 37509240›Full record

ArticleCancers2023

MRI Apparent Diffusion Coefficient (ADC) as a Biomarker of Tumour Response: Imaging-Pathology Correlation in Patients with Hepatic Metastases from Colorectal Cancer (EORTC 1423).

Alan Jackson, Ryan Pathak, Nandita M deSouza, Yan Liu, Bart K M Jacobs, Saskia Litiere, Maria Urbanowicz-Nijaki, Catherine Julie, Arturo Chiti, Jens Theysohn and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Alan JacksonCentre for Imaging Sciences, University of Manchester, Manchester M20 4GJ, UK.
Ryan PathakCentre for Imaging Sciences, University of Manchester, Manchester M20 4GJ, UK.
Nandita M deSouzaCRUK Cancer Imaging Centre, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Downs Road, London SW7 3RP, UK.ORCID 0000-0003-4232-476X
Yan LiuEuropean Organisation for Research and Treatment of Cancer, 1200 Brussels, Belgium.ORCID 0000-0001-8641-7939
Bart K M JacobsEuropean Organisation for Research and Treatment of Cancer, 1200 Brussels, Belgium.
Saskia LitiereEuropean Organisation for Research and Treatment of Cancer, 1200 Brussels, Belgium.
Maria Urbanowicz-NijakiEuropean Organisation for Research and Treatment of Cancer, 1200 Brussels, Belgium.
Catherine JulieEA 4340 BECCOH, UVSQ, Universite Paris-Saclay, 92104 Boulogne-Billancourt, France.
Arturo ChitiNuclear Medicine Unit, IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy.
Jens TheysohnInstitute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany.ORCID 0000-0001-5869-7929
Juan R AyusoRadiology Department-CDI, Hospital Clinic Universitari de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-5306-6850
Sigrid StroobantsMolecular Imaging and Radiology, University of Antwerp, 2000 Antwerp, Belgium.
John C WatertonCentre for Imaging Sciences, University of Manchester, Manchester M20 4GJ, UK.ORCID 0000-0002-7734-2290

Funding

European Union 115151
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diffusion-weighted MRImulticentre trialsquality assurancequantitationstandardisation

Identifiers

PMID37509240
PMCPMC10377224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.